Form 8.3 - Horizon Therapeutics plc

LONDON--()-- 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

  1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Horizon Therapeutics plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BQPVQZ61

Date of dealing

4th April 2023

2. INTERESTS AND SHORT POSITIONS

  1. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

4,252,383

(1.859%)

23,466

(0.010%)

(2) Derivatives (other than options)

-

-

(3) Options and agreements to purchase/sell

205,500

(0.090%)

828,900

(0.362%)

Total

4,457,883

(1.949%)

852,366

(0.373%)

b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

3. DEALINGS (Note 4)

  1. Purchases and sales

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (USD) (Note 5)

108.88

53

108.88

108.85

131

108.85

108.35

392

108.35

108.42

100

108.42

108.33

1,153

108.33

108.36

500

108.36

108.37

100

108.37

108.30

255

108.30

108.84

50

108.84

108.80

550

108.80

108.85

200

108.85

108.82

50

108.82

108.66

100

108.66

108.79

134

108.79

108.48

2

108.48

108.74

100

108.74

108.54

5,739

108.54

108.85

458

108.85

108.77

916

108.77

108.86

372

108.86

108.78

204

108.78

108.35

612

108.35

108.92

181

108.92

108.82

201

108.82

108.53

360

108.53

108.76

271

108.76

108.52

919

108.52

108.57

53

108.57

108.42

154

108.42

108.33

671

108.33

108.45

67

108.45

108.46

72

108.46

108.83

497

108.83

108.29

139

108.29

108.43

11

108.43

108.35

26

108.35

108.54

41

108.54

108.80

38

108.80

108.85

21

108.85

108.60

14

108.60

108.35

40

108.35

108.82

11

108.82

108.76

47

108.76

108.57

27

108.57

108.42

40

108.42

108.79

10

108.79

108.87

14

108.87

108.71

102

108.71

108.36

41

108.36

108.43

21

108.43

108.54

9,758

108.54

108.34

106

108.34

108.80

22

108.80

108.88

660

108.88

108.72

1

108.72

108.60

14

108.60

108.35

1,800

108.35

108.59

13

108.59

108.58

510

108.58

108.89

659

108.89

108.52

1,120

108.52

108.57

78

108.57

108.42

2

108.42

108.33

2,459

108.33

108.79

578

108.79

108.87

59

108.87

108.27

100

108.27

108.28

400

108.28

108.30

700

108.30

108.31

1,048

108.31

108.48

2

108.48

108.70

200

108.70

108.84

262

108.84

108.85

58

108.85

108.86

2

108.86

108.61

10

108.61

108.72

10

108.72

108.78

231

108.78

108.82

139

108.82

108.66

2,051

108.66

108.89

2

108.89

108.53

1

108.53

108.76

170

108.76

108.33

482

108.33

108.47

10

108.47

108.71

2

108.71

108.36

30

108.36

108.37

30

108.37

108.40

79

108.40

108.67

100

108.67

b. Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit (USD)

(Note 5)

 

 

 

 

c. Options transactions in respect of existing relevant securities

  1. Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

(USD)

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Put Option

Selling

400

90.00

American

5/19/2023

 

Put Option

Selling

1,200

80.00

American

5/19/2023

 

Put Option

Selling

100

80.00

American

1/17/2025

 

Put Option

Selling

100

90.00

American

1/19/2024

 

Put Option

Selling

1,600

105.00

American

6/16/2023

 

Put Option

Selling

3,900

105.00

American

7/21/2023

 

Put Option

Selling

2,700

105.00

American

4/21/2023

 

ii. Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

 

  1. Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure

5th April 2023

Contact name

Roisin Nagle

Telephone number

+44 203 192 8746

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making
disclosure:

Millennium International Management LP

Name of offeror/offeree in relation
to whose relevant securities the
disclosure relates:

Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of
relevant
security

Product
description
e.g. call
option

Written or
purchased

Number of
securities to
which option
or derivative
relates

Exercise
price
per unit

(USD)

Type
e.g.
American,
European
etc.

Expiry
date

IE00BQPVQZ61

Put Option

Purchased

1,100

90.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Purchased

11,500

110.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Written

262,300

115.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Purchased

42,500

120.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

5,200

110.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

2,900

80.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

300

80.00

American

1/17/2025

IE00BQPVQZ61

Put Option

Purchased

300

90.00

American

1/19/2024

IE00BQPVQZ61

Call Option

Purchased

1,200

110.00

American

8/18/2023

IE00BQPVQZ61

Call Option

Written

1,200

115.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Written

50,000

80.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

29,000

80.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

251,600

100.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

3,600

105.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

10,900

105.00

American

7/21/2023

IE00BQPVQZ61

Put Option

Purchased

5,200

105.00

American

4/21/2023

IE00BQPVQZ61

Call Option

Written

100,000

115.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Written

100,000

85.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

155,000

100.00

American

6/16/2023

IE00BQPVQZ61

Call Option

Purchased

300

110.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

300

110.00

American

6/16/2023

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET
Sequence Number: 1079321
Time of Receipt (offset from UTC): 20230405T124824+0100

Contacts

Millennium Partners, L.P.

Contacts

Millennium Partners, L.P.